✦ LIBER ✦

A world of low molecular weight heparins (LMWHs) enoxaparin as a promising moiety—A review

✍ Scribed by Ingle, Rahul G.; Agarwal, Aayush S.

Book ID: 125419154
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 192 KB
Volume: 106
Category: Article
ISSN: 0144-8617
DOI: 10.1016/j.carbpol.2014.01.100

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dendrimers as a carrier for pulmonary de

Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin

✍ Shuhua Bai; Chandan Thomas; Fakhrul Ahsan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

Human pharmacology of a low-molecular-we

Human pharmacology of a low-molecular-weight heparin (ALFA-LMWH): An update

✍ A. G. Dettori; M. Babbini 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB

Interaction of a new low molecular weigh

Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets

✍ Roberto Mastacchi; Mariam Barbanti; Pietro Bianchini; Bruna Osima 📂 Article 📅 1986 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 212 KB

Ultrasonic-assisted preparation of a low

Ultrasonic-assisted preparation of a low molecular weight heparin (LMWH) with anticoagulant activity

✍ Achour, Oussama; Bridiau, Nicolas; Godhbani, Azza; Le Joubioux, Florian; Bordena 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 914 KB

Diagnostic Procedures Of Delayed-type Hy

Diagnostic Procedures Of Delayed-type Hypersensitivity (DTH) Reactions To Low Molecular Weight Heparins (LMWHs)

✍ Vila, C.; Rosado, A.; Almanzar, W.L.; Moro, M.M.; Alonso, M.D.; Acosta, M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Polyproline-type helical-structured low-

Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor

✍ Esak Lee; Yoo-Shin Kim; Sang Mun Bae; Sang Kyoon Kim; Shunji Jin; Seung Woo Chun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 721 KB

## Abstract Although heparin can regulate angiogenesis, tumor growth and metastasis, its clinical application, as well as that of low‐molecular heparin (LMWH), for treating cancer are limited because of heparin's anticoagulant activity and risk of hemorrhages. LMWH‐taurocholate conjugates (LHT7), w